Maravai Lifesciences Holdings (MRVI) Work In Process (2020 - 2026)

Maravai Lifesciences Holdings' Work In Process history runs 7 years deep, the most recent figure standing at $9.0 million for Q1 2026.

• On a quarterly basis, Work In Process fell 9.44% year-over-year to $9.0 million in Q1 2026; TTM through Mar 2026 was $9.0 million, a 9.44% decrease from a year earlier, with the FY2025 full-year figure at $7.3 million, down 27.18% from the prior year.
• Work In Process grew to $9.0 million in Q1 2026 per MRVI's latest filing, from $7.3 million in the prior quarter.
• Across five years, Work In Process topped out at $30.6 million in Q3 2022 and bottomed at $7.3 million in Q4 2025.
• The 5-year median for Work In Process is $12.2 million (2023), against an average of $15.0 million.
• Across the five-year window, Work In Process soared 30.73% in 2022 and plunged 60.06% in 2023, its largest moves.
• Year by year, Work In Process stood at $22.0 million in 2022, then sank by 42.23% to $12.7 million in 2023, then fell by 20.74% to $10.0 million in 2024, then retreated by 27.18% to $7.3 million in 2025, then rose by 22.7% to $9.0 million in 2026.
• Per Business Quant, the three latest MRVI Work In Process figures stand at $9.0 million (Q1 2026), $7.3 million (Q4 2025), and $9.7 million (Q3 2025).